Financial Statements

  Year Ending Apr 2018 (Update) Year Ending Apr 2017 (Update) Year Ending Apr 2016 (Update) Year Ending May 2015 (Update)
Net Sales 610.53 586.54 570.17 615.94
Revenue 610.53 586.54 570.17 615.94
Total Revenue 610.53 586.54 570.17 615.94
Cost of Revenue 464.86 446.12 449.15 471.36
Cost of Revenue, Total 464.86 446.12 449.15 471.36
Gross Profit 145.67 140.42 121.02 144.58
Selling/General/Administrative Expense 96.18 94.31 89.99 86.91
Labor & Related Expense 1.50 1.60 1.62 1.73
Selling/General/Administrative Expenses, Total 97.68 95.91 91.61 88.64
Research & Development 35.53 29.08 26.91 24.65
Impairment-Assets Held for Use
Other Unusual Expense (Income)
Unusual Expense (Income)
Total Operating Expense 598.07 571.12 567.67 584.66
Operating Income 12.46 15.42 2.50 31.29
Interest Expense - Non-Operating -0.22 -0.23 -0.23 -0.22
Interest Expense, Net Non-Operating -0.22 -0.23 -0.23 -0.22
Interest Income, Non-Operating 0.72 0.75 0.99 1.12
Investment Income, Non-Operating -0.45 -0.47 -0.33 -0.51
Interest/Investment Income, Non-Operating 0.27 0.28 0.66 0.61
Interest Income (Expense), Net-Non-Operating, Total 0.05 0.05 0.43 0.38
Other Non-Operating Income (Expense) -0.09 0.11 0.20 0.02
Other, Net -0.09 0.11 0.20 0.02
Net Income Before Taxes 12.43 15.59 3.13 31.68
Income Tax – Total 3.05 5.25 1.07 10.80
Income After Tax 9.38 10.34 2.06 20.88
Net Income Before Extraordinary Items 9.38 10.34 2.06 20.88
Extraordinary Item -3.82
Total Extraordinary Items -3.82
Net Income 5.56 10.34 2.06 20.88
Income Available to Common Excluding Extraordinary Items 9.38 10.34 2.06 20.88
Income Available to Common Stocks Including Extraordinary Items 5.56 10.34 2.06 20.88
Basic Weighted Average Shares 44.46 44.11 43.99 43.51
Basic EPS Excluding Extraordinary Items 0.21 0.23 0.05 0.48
Basic EPS Including Extraordinary Items 0.13 0.23 0.05 0.48
Dilution Adjustment
Diluted Net Income 5.56 10.34 2.06 20.88
Diluted Weighted Average Shares 44.87 44.30 44.46 44.44
Diluted EPS Excluding Extraordinary Items 0.21 0.23 0.05 0.47
Diluted EPS Including Extraordinary Items 0.12 0.23 0.05 0.47
DPS - Common Stock Primary Issue 0.35 0.47 0.40 0.38
Gross Dividends - Common Stock 12.42 13.65 17.56 17.38
Total Special Items
Normalized Income Before Taxes 12.43 15.59 3.13 31.68
Effect of Special Items on Income Taxes
Income Taxes Excluding Impact of Special Items 3.05 5.25 1.07 10.80
Normalized Income After Taxes 9.38 10.34 2.06 20.88
Normalized Income Available to Common 9.38 10.34 2.06 20.88
Basic Normalized EPS 0.21 0.23 0.05 0.48
Diluted Normalized EPS 0.21 0.23 0.05 0.47
Amortization of Intangibles, Supplemental 0.30 0.20
Depreciation, Supplemental 16.27 16.73 16.56 14.76
Interest Expense, Supplemental 0.22 0.23 0.23 0.22
Rental Expense, Supplemental 3.48 3.18 2.73 2.71
Stock-Based Compensation, Supplemental 2.64 2.91 2.96 3.04
Advertising Expense, Supplemental 2.86 2.13 2.21 2.32
Equity in Affiliates, Supplemental -0.48 -0.14
Research & Development Expense, Supplemental 35.53 29.08 26.91 24.65
Audit-Related Fees, Supplemental 0.95 0.89 0.86 0.72
Audit-Related Fees 0.04 0.03 0.03 0.03
Tax Fees, Supplemental 0.03
All Other Fees Paid to Auditor, Supplemental 0.07 0.00 0.00 0.00
Gross Margin 23.86 23.94 21.23 23.47
Operating Margin 2.04 2.63 0.44 5.08
Pretax Margin 2.04 2.66 0.55 5.14
Effective Tax Rate 24.52 33.65 34.07 34.09
Net Profit Margin 1.54 1.76 0.36 3.39
Normalized EBIT 12.46 15.42 2.50 31.29
Normalized EBITDA 28.73 32.15 19.35 46.25
Current Tax - Domestic 1.36 5.27 -0.47 6.66
Current Tax - Foreign 1.21 0.86 0.56 0.85
Current Tax - Local 0.87 1.16 0.12 1.15
Current Tax - Total 3.43 7.29 0.21 8.66
Deferred Tax - Domestic 0.16 -1.63 0.46 1.91
Deferred Tax - Foreign -0.57 -0.02 0.48 -0.07
Deferred Tax - Local 0.03 -0.40 -0.09 0.31
Deferred Tax - Total
Deferred Tax - Total -0.39 -2.04 0.85 2.15
Income Tax - Total 3.05 5.25 1.07 10.80
Defined Contribution Expense - Domestic 2.46 2.32 2.14
Total Pension Expense 2.46 2.32 2.14

In millions of USD (except for per share items)

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Morningstar